AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$11.82
−$0.08 (−0.63%) 3:45 PM ET
Prev closePrevC$11.89
OpenOpen$12.04
Day highHigh$12.04
Day lowLow$11.75
VolumeVol1,562,920
Avg volAvgVol3,045,682
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$2.21B
P/E ratio
-15.55
FY Revenue
$2.82B
EPS
-0.76
Gross Margin
13.09%
Sector
Industrials
AI report sections
BEARISH
DNOW
DNOW Inc.
DNOW Inc. shows upward price momentum with the latest close above short- and medium-term moving averages and near the upper half of its 52-week range, supported by bullish breakout technical patterns and elevated RSI. Fundamentally, the company combines modest revenue growth, double-digit net income and EPS growth, positive free cash flow, and a debt-free balance sheet, while facing thin operating and net margins and a decline in operating cash flow growth. Valuation multiples, including a P/E above 30 and EV/EBITDA above 15, appear relatively elevated versus the company’s low single-digit revenue growth and mid-single-digit margins, with short interest and neutral legal-focused news adding a measured risk backdrop.
AI summarized at 1:38 AM ET, 2026-02-03
AI summary scores
INTRADAY:68SWING:72LONG:63
Volume vs average
Intraday (cumulative)
−4% (Below avg)
Vol/Avg: 0.96×
RSI
43.97(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
+0.00 (Strong)
MACD: -0.00 Signal: -0.01
Short-Term
+0.06 (Strong)
MACD: -0.11 Signal: -0.17
Long-Term
+0.08 (Strong)
MACD: -0.55 Signal: -0.63
Intraday trend score
43.82
LOW43.82HIGH63.82
Latest news
DNOW•12 articles•Positive: 0Neutral: 3Negative: 9
NegativeGlobeNewswire Inc.• Rosen Law Firm
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims against DNOW Inc. (NYSE: DNOW) for allegedly issuing materially misleading business information. The investigation was triggered after DNOW reported disappointing fourth-quarter 2025 financial results with significant losses that missed Wall Street expectations, causing the stock to fall 19.1% on February 20, 2026. The firm is preparing a class action lawsuit to recover investor losses.
The company is under investigation for issuing materially misleading business information, reported disappointing Q4 2025 results with significant losses, missed Wall Street expectations, and experienced a sharp 19.1% stock decline on the news announcement.
NegativeGlobeNewswire Inc.• The Rosen Law Firm
מידע למשקיעי DNOW: אם סבלתם הפסדים ב- DNOW Inc. (NYSE: DNOW), אתם מוזמנים ליצור קשר עם משרד רוזן עורכי דין בנוגע לזכויותיכם.
The Rosen Law Firm is investigating potential securities claims against DNOW Inc. following the company's disappointing Q4 2025 financial results. The stock declined 19.1% on February 20, 2026, after reporting significant losses and missing Wall Street expectations. Investors who purchased DNOW securities may be eligible for compensation through a class action lawsuit.
The company is the subject of a securities investigation due to allegedly publishing materially misleading business information. Q4 2025 results were disappointing with significant losses and missed Wall Street expectations, resulting in a 19.1% stock price decline.
NegativeGlobeNewswire Inc.• Rosen Law Firm
ROSEN, THE FIRST FILING FIRM, Encourages Franklin BSP Realty Trust, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FBRT
Rosen Law Firm is encouraging investors who purchased securities of Franklin BSP Realty Trust (FBRT) between November 5, 2024 and February 11, 2026 to join a securities class action lawsuit. The firm alleges that defendants made false and misleading statements about the company's prospects and its ability to maintain its $0.355 dividend. The lead plaintiff deadline is April 27, 2026. The firm is also investigating potential securities claims for Driven Brands Holdings Inc. (DRVN) and DNOW Inc. (DNOW).
FBRTFBRTPEDRVNDNOWsecurities class actionfalse statementsmisleading disclosuresdividend
Sentiment note
Company is mentioned as subject to potential securities claims investigation by Rosen Law Firm, indicating alleged shareholder losses and potential legal violations.
NegativeGlobeNewswire Inc.• The Rosen Law Firm
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm is investigating potential securities claims against DNOW Inc. after the company reported disappointing fourth-quarter 2025 financial results that missed Wall Street expectations, causing the stock to fall 19.1% on February 20, 2026. Investors who suffered losses are encouraged to join a prospective class action lawsuit.
DNOWsecurities fraudclass action lawsuitmisleading business informationdisappointing financial resultsstock decline
Sentiment note
Company issued materially misleading business information, reported disappointing Q4 2025 results with significant losses that missed Wall Street expectations, resulting in a 19.1% stock price decline and triggering a securities investigation and class action lawsuit.
NegativeGlobeNewswire Inc.• Rosen Law Firm
ALDX Investor News: If You Have Suffered Losses in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm announced investigations into potential securities claims against Aldeyra Therapeutics (ALDX), DNOW Inc. (DNOW), and Gartner, Inc. The primary focus is on Aldeyra, which received an FDA Complete Response Letter rejecting its reproxalap drug application due to lack of efficacy evidence in dry eye disease treatment, causing the stock to plummet 70.7% on March 17, 2026.
ALDXDNOWITsecurities class actionFDA rejectiondrug efficacyinvestor lossesstock decline
Sentiment note
The company is subject to a securities investigation by Rosen Law Firm for potential securities claims, indicating alleged misconduct or misleading disclosures to investors.
NegativeGlobeNewswire Inc.• The Rosen Law Firm
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm is investigating potential securities claims against DNOW Inc. after the company reported disappointing fourth-quarter 2025 financial results that missed Wall Street expectations, causing the stock to fall 19.1% on February 20, 2026. Investors who suffered losses are encouraged to join a prospective class action lawsuit.
DNOWsecurities fraudclass action lawsuitmisleading business informationQ4 2025 earningsstock declineinvestor losses
Sentiment note
Company reported disappointing fourth-quarter 2025 financial results with significant losses and missed Wall Street expectations, resulting in a 19.1% stock decline and triggering a securities investigation for allegedly issuing materially misleading business information.
NegativeGlobeNewswire Inc.• The Rosen Law Firm
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm is investigating potential securities claims against DNOW Inc. after the company reported disappointing fourth-quarter 2025 financial results that missed Wall Street expectations, causing the stock to plummet 19.1% on February 20, 2026. Investors who suffered losses are encouraged to join a prospective class action lawsuit.
DNOWsecurities fraudclass action lawsuitmisleading business informationQ4 2025 earningsstock declineinvestor losses
Sentiment note
Company reported disappointing fourth-quarter 2025 financial results with significant losses and missed Wall Street expectations, resulting in a 19.1% stock price decline and triggering a securities investigation for allegedly issuing materially misleading business information.
NegativeGlobeNewswire Inc.• The Rosen Law Firm
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm is investigating potential securities claims against DNOW Inc. after the company reported disappointing fourth-quarter 2025 financial results that missed Wall Street expectations, causing the stock to plummet 19.1% on February 20, 2026. Investors who purchased DNOW securities may be eligible for compensation through a class action lawsuit.
DNOWsecurities class actionmisleading business informationQ4 2025 resultsstock declineinvestor lossesshareholder litigation
Sentiment note
Company reported disappointing fourth-quarter 2025 financial results with significant losses that missed Wall Street expectations, resulting in a 19.1% stock price decline and triggering a securities investigation for allegedly issuing materially misleading business information.
NegativeThe Motley Fool• Eric Volkman
Why DNOW Stock Got Rocked on Friday
DNOW stock plummeted 19% after missing earnings expectations on both revenue and net income in Q4 2025. While revenue nearly doubled to $959M due to the MRC Global acquisition, the company fell short of analyst estimates. Integration challenges with MRC Global's legacy ERP system are creating near-term obstacles, prompting the analyst to recommend waiting for tangible progress before investing.
DNOWearnings missacquisition integrationERP system challengesrevenue growthnet income decline
Sentiment note
Stock fell 19% due to missing analyst consensus on both revenue ($959M vs. expected $988M) and adjusted net income ($0.15 vs. expected $0.16 per share). Additionally, integration challenges with the MRC Global acquisition's legacy ERP system pose near-term obstacles to growth prospects.
NeutralGlobeNewswire Inc.• Charles C. Foti, Jr.
MRC GLOBAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of MRC Global Inc. - MRC
Law firm Kahn Swick & Foti is investigating the proposed sale of MRC Global Inc. to DNOW Inc., questioning whether the transaction adequately values the company.
MRCDNOWmergeracquisitionshareholder investigation
Sentiment note
No definitive positive or negative assessment, as the investigation is ongoing to determine transaction adequacy
NeutralThe Motley Fool• Jesterai
MRC Global (MRC) Q2 Revenue Rises 12%
MRC Global reported Q2 2025 earnings with $798 million in revenue, beating analyst expectations, but experiencing margin contraction and a year-over-year decline in net income. The company is preparing for a merger with DNOW and focusing on digital transformation and supply chain efficiency.
MRCDNOWearningsrevenuemergerdigital commerceenergy distribution
Sentiment note
Mentioned as a merger partner with MRC Global, no specific performance details provided
NeutralGlobeNewswire Inc.• Halper Sadeh Llc
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRC, DNOW, AVDX on Behalf of Shareholders
Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for multiple companies, including MRC Global, DNOW, and AvidXchange, related to proposed mergers and acquisitions.
MRCDNOWAVDXshareholderinvestigationmergeracquisitionsecurities law
Sentiment note
Proposed merger with MRC Global under investigation, shareholders will own 56.5% of combined company
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal
